Related Experiment Videos
[Concomitant diseases in primary joint hypermobility syndrome]
Martin Skoumal1, Günther Haberhauer, Hans Mayr
1Institut für Rheumatologie der Kurstadt Baden in Kooperation mit der Donauuniversität Krems,Vienna, Austria. martin.skoumal@a1.net
Summary
Primary joint hypermobility syndrome (pJH) is a connective tissue disorder overlapping with Marfan and Ehlers-Danlos syndromes. Early recognition of life-threatening complications like aortic root dilatation is crucial for patients with pJH.
Area of Science:
- Connective tissue disorders
- Genetics and rare diseases
Background:
- Primary joint hypermobility syndrome (pJH) is an overlap disorder of connective-tissue dysplasias.
- It shares features with Marfan syndromes (MFS), Ehlers-Danlos syndromes (EDS), and osteogenesis imperfecta.
- Patients commonly experience joint pain, dislocations, and various extra-articular manifestations.
Purpose of the Study:
- To highlight the importance of recognizing primary joint hypermobility syndrome (pJH).
- To emphasize the need for early identification of potentially life-threatening complications.
- To stress the significance of screening for features of MFS and EDS in pJH patients.
Main Methods:
- This study is a review of the clinical features and implications of primary joint hypermobility syndrome (pJH).
- It synthesizes information on the overlap between pJH and other connective tissue disorders.
- Focuses on identifying critical and life-threatening manifestations.
Main Results:
- pJH presents with arthralgia, back pain, dislocations, and extra-articular signs like striae, keratoconus, and mitral valve prolapse.
- Life-threatening complications include aortic root dilatation, aneurysms, and pneumothorax.
- Early recognition is vital due to the risk of dissection and rupture.
Conclusions:
- Primary joint hypermobility syndrome (pJH) requires comprehensive evaluation beyond joint symptoms.
- Screening for cardiovascular and other severe manifestations associated with MFS and EDS is essential.
- Prompt diagnosis and monitoring can mitigate risks of critical complications in pJH patients.